Brind.

Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.

2 reports, 1 independent Updated 00:00

Still developing

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.

Who's involved

What this event is mainly about

Eli Lilly and Company European Society for Medical Oncology

Keep exploring

The entities involved

Eli Lilly and Company
American pharmaceutical company
- Eli Lilly and Company acquired Point and established a supply agreement with EUZ.06:37
- Major pharmaceutical companies, including Viking Therapeutics, Eli Lilly, and Novo Nordisk, are advancing their weight loss drug pipelines.Sun 23:36
European Society for Medical Oncology
Professional organisation
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.08:04
- Faron Pharmaceuticals presented clinical data at the ESMO Congress on October 19, 2026.07:59

Related events

Researchers presented Phase 3 clinical data at the European Society for Medical Oncology (ESMO) Congress on September 21, 2026.Sep 21
Acquisition of ImClone Systems provided an oncology franchise.Oct 7

Coverage

Newest first; wire copies grouped

00:00prnewswire.com
Sun 00:00prnewswire.com